Where does Inflectis Bioscience rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Inflectis Bioscience ranks #32,048 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Inflectis Bioscience hold?

Inflectis Bioscience holds 8 US utility patents granted between 2017 and 2021, spanning 5 technology areas.

What is Inflectis Bioscience's Innovation Score?

Inflectis Bioscience has an Innovation Score of 25.4 out of 100 (17th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Inflectis Bioscience focus on?

Inflectis Bioscience's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 8 patents, ranking #2,286 of 6,058 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Inflectis Bioscience's patent grant rate increasing or decreasing?

Inflectis Bioscience's recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Inflectis Bioscience's patents?

Inflectis Bioscience's patents average 16.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Inflectis Bioscience patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Inflectis Bioscience

USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2017–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Inflectis ranks #32,048 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.

#32,048
of 49,997 US assignees by volume: 17th percentile
by Innovation Score (25.4/100): 16.5
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R32048 · Foreign Corporation #32,048 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #32,048/49,997
PHOTO-FINISH Indian Space…
CPC-NARROW A61P · 5 areas
INNOV-THIN 25.4/100
CLAIMS-RICH 16.5 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Indian Space Research Organization (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Inflectis’s 25.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (30%) Velocity 0.0 pts (0%) Breadth 7.9 pts (31%) Claim depth 9.9 pts (39%)

Qualcomm Incorporated · highest

85
Alkhorayef Petroleum · near

25
Clear LAM Packaging · near

25
Inflectis Bioscience · this assignee

25
Dupont Teijin… · near

25
Shenzhen Qianhai… · near

25
3D Lighting… · lowest

7

What this shows Inflectis's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Inflectis?

Each dot is one of Inflectis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Inflectis’s own 16.5 claims/patent is ABOVE the 10.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Inflectis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Inflectis's grants concentrate

Inflectis Bioscience is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2017. By volume, Inflectis sits between Indian Space Research Organization and Ingu Solutions Inc..

Indian Space Rese…

8
Indian Statistica…

8
Industrial Bank O…

8
Industro Internat…

8
Infopia

8
Information Syste…

8
Ingine

8
Ingu Solutions

8
Inflectis Bioscie… ◀

8

What this shows Inflectis holds 8 patents at rank #32,009, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Inflectis

By rank, the assignees closest to #32,009 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Inflectis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Inflectis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Inflectis ranks #2,286 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (25 here).

Clear LAM Packaging, Inc. 25 Dupont Teijin Advanced Papers (JAPAN), Ltd. 25 Shenzhen Qianhai Patuoxun Network AND Technology Co., Ltd. 25 Alkhorayef Petroleum Company 25

Inflectis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Inflectis Bioscience patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	12.5%
2018	1	12.5%
2020	4	50.0%
2021	2	25.0%

Which technologies does Inflectis Bioscience patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C07D - Heterocyclic Compounds 6

C07C - Acyclic OR Carbocyclic Compounds 6

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Inflectis Bioscience's patent record in context - here's where to go next.

Inflectis Bioscience's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #32,048 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Inflectis Bioscience against Indian Space Research Organization, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.